The focus of the lab includes proteomics, mass spectrometry and cancer biology. We are interested in both basic biology and translational research. Our translational research is focused on biomarker development using proteomics and proteogenomics technologies. Our basic biology interest is to study the function of novel cell surface proteins – in collaboration with industry, we aim to develop novel antibody therapeutics.
Thomas Kislinger, PhD
Senior Scientist, Princess Margaret Cancer Centre
Keywords: proteomics, mass spectrometry, cancer biomarkers, exosomes, membrane proteins